Home / Import refusals / 605-1163450-7/21/1

FDA Import Refusal 605-1163450-7/21/1 — Thymoorgan Pharmazie Gmbh

Thymoorgan Pharmazie Gmbh — FEI 3002320821

The FDA refused shipment 605-1163450-7/21/1 from Thymoorgan Pharmazie Gmbh (Germany) on October 31, 2022. The refused product falls under Drugs and Biologics — DOXORUBICIN HYDROCHLORIDE (ANTITUMOR). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
October 31, 2022
Country
Germany
Product Category
Drugs and Biologics
Product Code
56HIK24 DOXORUBICIN HYDROCHLORIDE (ANTITUMOR)
Charges
75

Recent inspections

  • 1203954 (VAI Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1207607 (VAI Thu Oct 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1123031 (VAI Thu Jun 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053793 (NAI Mon Apr 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003153 (NAI Fri Dec 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-9434036-9/10002/1 (Wed Mar 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 605-1163450-7/31/1 (Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 605-1163453-1/11/1 (Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 605-1163453-1/21/1 (Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 253-0103304-6/1/1 (Wed Feb 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources